Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Vicentini

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Non-Coding RNA Research|January 1, 2020
Current role of non-coding RNAs in the clinical settingCaterina Vicentini, Francesca Galuppini, Vincenzo Corbo, et al.
Current Drug Targets|December 16, 2014
MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesisEdoardo D'Angelo, Caterina Vicentini, Marco Agostini, et al.
Molecules (Basel, Switzerland)|February 26, 2014
Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tractCaterina Vicentini, Matteo Fassan, Edoardo D'Angelo, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinomaStefano Marletta, Denise Fiorini, Anna Caliò, et al.
BMC Cancer|January 13, 2016
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changesEliana Amato, Stefano Barbi, Matteo Fassan, et al.
Journal of Visualized Experiments : Jove|November 26, 2019
Comparative Lesions Analysis Through a Targeted Sequencing ApproachCaterina Vicentini, Andrea Mafficini, Michele Simbolo, et al.
Carcinogenesis|June 30, 2018
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complexAnastasios Gkountakos, Sara Pilotto, Andrea Mafficini, et al.
Current Oncology Reports|July 16, 2021
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?Claudio Luchini, Rita T Lawlor, Samantha Bersani, et al.
Epidemiology and Infection|February 21, 2022
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalenceMaddalena Cordioli, Massimo Mirandola, Lorenzo Gios, et al.
European Journal of Endocrinology|February 21, 2015
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangementsChiara Colato, Caterina Vicentini, Silvia Cantara, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Non-Coding RNA Research|January 1, 2020
Current role of non-coding RNAs in the clinical settingCaterina Vicentini, Francesca Galuppini, Vincenzo Corbo, et al.
Current Drug Targets|December 16, 2014
MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesisEdoardo D'Angelo, Caterina Vicentini, Marco Agostini, et al.
Molecules (Basel, Switzerland)|February 26, 2014
Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tractCaterina Vicentini, Matteo Fassan, Edoardo D'Angelo, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2026
Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinomaStefano Marletta, Denise Fiorini, Anna Caliò, et al.
BMC Cancer|January 13, 2016
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changesEliana Amato, Stefano Barbi, Matteo Fassan, et al.
Journal of Visualized Experiments : Jove|November 26, 2019
Comparative Lesions Analysis Through a Targeted Sequencing ApproachCaterina Vicentini, Andrea Mafficini, Michele Simbolo, et al.
Carcinogenesis|June 30, 2018
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complexAnastasios Gkountakos, Sara Pilotto, Andrea Mafficini, et al.
Current Oncology Reports|July 16, 2021
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?Claudio Luchini, Rita T Lawlor, Samantha Bersani, et al.
Epidemiology and Infection|February 21, 2022
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalenceMaddalena Cordioli, Massimo Mirandola, Lorenzo Gios, et al.
European Journal of Endocrinology|February 21, 2015
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangementsChiara Colato, Caterina Vicentini, Silvia Cantara, et al.
Pageof 5